Corrigendum | Open Access
Bo Qiu, Ming Gong, Qi-Ting He, Pang-Hu Zhou, "Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”", BioMed Research International, vol. 2020, Article ID 6942710, 2 pages, 2020. https://doi.org/10.1155/2020/6942710
Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”
In the article titled “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes” , there were several errors including the inadvertent reuse of images from the authors’ earlier work, errors in the primers, and a lack of a reference to the authors’ related article from which they reused wording.
The authors raised to the attention of the journal an error in Figure 1, where the images were incorrectly reused from those in the article titled “Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres” in BMC Musculoskeletal Disorders . The authors sincerely apologize for their carelessness and for this error. The figure should be corrected as follows:
The authors did not discuss their related work in Molecular Medicine Reports, from which they reused around 1000 words . That article mainly exploited the controlled release of interleukin-1 receptor antagonist from chitosan microspheres without hyaluronic acid. In this study, the authors investigated the protective effect of interleukin-1 receptor antagonist on IL-1β-induced inflammation and apoptosis including MTT assay, NO2-, prostaglandin E2, B-cell lymphoma 2, Bcl-2-associated X protein, and caspase-3 expressions at mRNA or protein levels; the previous work only studied the effect of inhibition of matrix metalloproteinases induced by IL-1β.
The primers for Bcl-2, Bax, Caspase-3, and beta-actin are specific to the human genes (as checked using Primer BLAST and BLASTn), but the cells used in the study are Sprague-Dawley rat chondrocytes. The authors say the incorrect primer information was collected during the writing of the article. Table 1 should be corrected as follows:
The Western Blots in Figure 7 were adjusted for contrast and exposure, and the original images are available in the supplementary materials.
Original images for the Western Blots in Figure 7 (BMRI 6290957 Figure 7 Western Blots.zip). (Supplementary materials)
- B. Qiu, M. Gong, Q.-T. He, and P.-H. Zhou, “Controlled release of interleukin-1 receptor antagonist from hyaluronic acid-chitosan microspheres attenuates interleukin-1β-induced inflammation and apoptosis in chondrocytes,” BioMed Research International, vol. 2016, Article ID 6290957, 12 pages, 2016.
- B.-l. Ma, P.-H. Zhou, T. Xie, L. Shi, B. Qiu, and Q. Wang, “Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres,” BMC Musculoskeletal Disorders, vol. 16, no. 1, p. 61, 2015.
- P. Zhou, B. Ma, L. Shi, T. Xie, and B. Qiu, “Inhibition of interleukin-1β-stimulated matrix metalloproteinases via the controlled release of interleukin-1Ra from chitosan microspheres in chondrocytes,” Molecular Medicine Reports, vol. 11, no. 1, pp. 555–560, 2015, https://www.spandidos-publications.com/10.3892/mmr.2014.2743.
Copyright © 2020 Bo Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.